NR4A1 and breast carcinoma: In this study, we analyzed a cohort of 74 hormone receptor positive breast cancer patients by performing a deep molecular characterization of treatment-naïve primary tumor samples and their matched metastatic localizations, to highlight putative mechanisms of endocrine resistance.